All patients (n = 1140) | Patients with peak values (n = 153) | Patients with trough values (n = 300) | |
---|---|---|---|
No of aFXa during ICU stay per patient, median (IQR) | - | 1 (1 to 3) | 2 (1 to 3) |
aFXa, minimum value during ICU stay, median (IQR), kIU/L | - | 0.41 (0.29 to 0.55) | 0.21 (0.14 to 0.34) |
aFXa, median value over the first 14 ICU days, median (IQR), kIU/L | - | (n = 126) 0.5 (0.34 to 0.64) | (n = 266) 0.29 (0.21 to 0.46) |
aFXa, maximum value during ICU stay, median (IQR), kIU/L | - | 0.55 (0.39 to 0.76) | 0.38 (0.24 to 0.56) |
Days in ICU, median (IQR) | 11 (5 to 22) | 19 (13 to 30) | 17 (9 to 28) |
Death within 90 days | 314 (27.5) | 55 (35.9) | 95 (31.7) |
Death in ICU | 258 (22.6) | 49 (32.0) | 88 (29.3) |
Any thromboembolism and/or bleeding | 378 (33.2) | 57 (37.3) | 117 (39.0) |
Thromboembolism | 160 (14.0) | 17 (11.1) | 37 (12.3) |
Pulmonary embolism/thrombosisa | 134 (11.8) | 14 (9.2) | 31 (10.3) |
Deep venous thrombosisb | 32 (2.8) | 3 (2.0) | 5 (1.7) |
Ischemic strokea | 11 (1.0) | 2 (1.3) | 3 (1.0) |
Bleedingc | 288 (25.2) | 48 (31.3) | 100 (33.3) |
Major bleedingd | 72 (6.3) | 15 (9.8) | 23 (7.7) |